Clinical implications of biocompatibility in blood purification membranes

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 2, 2000, Pages 16-20

  Hakim, R M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOMATERIAL; CELLULOSE; CELLULOSE ACETATE; COMPLEMENT; KALLIKREIN; POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE; REACTIVE OXYGEN METABOLITE;

ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; LONG TERM CARE; LYMPHOCYTE; MONOCYTE; MORTALITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0033825117     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_1.16     Document Type: Article

References (54)

1. Membranes
2. Dyspnea, back pain, and hypotension during a vacation hemodialysis
3. Anaphylatoxin formation in extracorporeal circuits
4. Biocompatibility of dialysis membranes: Effects of chronic complement activation
5. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors
6. Anaphylactoid reactions in hemodialysis patients treated with AN69 dialyzers
7. Bradykinin generation by dialysis membranes: Possible role in anaphylactic reaction
8. α-Thromboglobulin and platelet factor 4 levels during hemodialysis
9. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis
10. Haemodialysis hypotension: The interleukin hypothesis restated
11. Systemic complement activation, lung injury, and products of lipid peroxidation
12. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis
13. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial
14. 2m synthesis in lymphocytes after exposure to cuprophane dialyzer membranes
15. Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes
16. Granulocyte complement interaction: A beneficial antimicrobial mechanism that can cause disease
17. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes
18. Biocompatibility of hemodialysis membranes
19. Fluid phase generation of the terminal complement complex C5b-9 as a novel index of biocompatibility
20. Prostaglandin production and extracorporeal complement activation by dialyzer membranes
21. Successful hemodialysis of patients at high risk of hemorrhage using the exval dialyzers
22. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation
23. Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep
24. Increased expression of an adhesion promoting surface glycoprotein in the granulocytopenia of hemodialysis
25. There is more than one interleukin-1
26. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes
27. Functional changes of monocytes due to dialysis membranes
28. Convective mass transport in dialysis
29. Effects of dialysis membranes on beta-2 microglobulin production and cellular expression
30. Natural killer-cell function in hemodialysis patients: Effect of the dialysis membrane
31. Compartmental distribution of complement activation products in artificial kidneys
32. Complement activation and hypersensitivity reactions to dialysis membranes
33. Allergy to a product of ethylene oxide gas-demonstration of IgE and IgG antibodies and hapten specificity
34. Anaphylactoid reactions in dialysis patients. Role of ethyleneoxide
35. Effect of multiple use of dialyzers on intradialytic symptoms
36. Effect of first and subsequent use of hemodialyzers on patient well being
37. Long-term results of dialysis therapy with a highly permeable membrane
38. Survival analysis of patients undergoing dialysis
39. Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study
40. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis
41. Switch from conventional to high-flux membrane reduces the role of carpal tunnel syndrome and mortality of hemodialysis patients
42. 2m
43. Hemodialysis membrane choice influences maintenance of residual renal function (RRF) in an animal model
44. The use of polysulfone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients
45. The effect of the dialysis membrane on mortality of chronic hemodialysis patients (CHD) in the U.S
46. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
47. Complement activation retards resolution of acute ischemic renal failure in the rat
48. Effect of the dialysis membrane in the treatment of patients with acute renal failure
49. A multicenter comparison of bioincompatible (BICM) and biocompatible (BCM) membranes in the treatment of acute renal failure (ARF)
50. Biocompatible membranes in acute renal failure: Prospective case-controlled study
51. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis
52. Haemodialysis membrane biocompatibility and mortality of patients with dialysis dependent acute renal failure: A prospective randomised multicentre trial
53. Clinical implications of hemodialysis membrane biocompatibility